Ambac Financial Group (OSG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Fiscal year 2024 featured two transformational transactions: sale of the legacy financial guarantee business to Oaktree Capital for $420 million and acquisition of a majority stake in Beat Capital Partners, expanding global insurance distribution capabilities.
Specialty Property and Casualty Insurance premiums rose 74% to $876 million, with Everspan gross premiums up 40% to $382 million and Cirrata premiums placed up 114% to $493 million.
Adjusted EBITDA to common stockholders increased 43% to $13 million, and total revenue from continuing operations grew 89% to $236 million.
The company reduced its combined ratio to 101.6% from 106.5% and cut gross operating run rate expenses to $13.9 million in Q4 2024.
Voting matters and shareholder proposals
Shareholders will vote to elect seven directors, approve executive compensation (say-on-pay), ratify KPMG LLP as independent auditor for 2025, and determine the frequency of future say-on-pay votes.
The board recommends voting for all director nominees, for executive compensation, for auditor ratification, and for annual say-on-pay votes.
Board of directors and corporate governance
Six of seven directors are independent; the board is diverse in gender and ethnicity, with three women and one Hispanic nominee.
Separate Chairman and CEO roles; average director tenure is 6.1 years.
Annual board and committee self-evaluations are conducted, and the board actively solicits shareholder feedback.
No classified board, no stockholder rights plan, and robust stockholder engagement practices.
Latest events from Ambac Financial Group
- Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 202524 Feb 2026 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Q3 net loss, 86% P&C premium growth, Beat acquisition, $50M buyback, legacy sale approved.OSG
Q3 202414 Jan 2026 - Revenue up 27% and P&C premium up 70%, but net loss widened on higher expenses.OSG
Q1 20257 Jan 2026 - Record premium growth and margin gains offset by $548M net loss from legacy business sale.OSG
Q4 202423 Dec 2025 - Vote on $420M sale of AAC to Oaktree, executive pay, and adjournment; board recommends approval.OSG
Proxy Filing2 Dec 2025 - Shareholders to vote on $420M sale, board-backed, with new capital and governance terms.OSG
Proxy Filing2 Dec 2025 - Vote requested on sale of Ambac Assurance Corporation and related executive compensation.OSG
Proxy Filing2 Dec 2025